Last reviewed · How we verify
Toms of Maine 0 ppm Fluoride Dentifrice
Toms of Maine 0 ppm Fluoride Dentifrice is a Small molecule drug developed by Procter and Gamble. It is currently in Phase 1 development.
At a glance
| Generic name | Toms of Maine 0 ppm Fluoride Dentifrice |
|---|---|
| Sponsor | Procter and Gamble |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Toms of Maine 0 ppm Fluoride Dentifrice CI brief — competitive landscape report
- Toms of Maine 0 ppm Fluoride Dentifrice updates RSS · CI watch RSS
- Procter and Gamble portfolio CI
Frequently asked questions about Toms of Maine 0 ppm Fluoride Dentifrice
What is Toms of Maine 0 ppm Fluoride Dentifrice?
Toms of Maine 0 ppm Fluoride Dentifrice is a Small molecule drug developed by Procter and Gamble.
Who makes Toms of Maine 0 ppm Fluoride Dentifrice?
Toms of Maine 0 ppm Fluoride Dentifrice is developed by Procter and Gamble (see full Procter and Gamble pipeline at /company/procter-and-gamble).
What development phase is Toms of Maine 0 ppm Fluoride Dentifrice in?
Toms of Maine 0 ppm Fluoride Dentifrice is in Phase 1.